100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting farmacotherapie bij ouderen $4.82
Add to cart

Summary

Samenvatting farmacotherapie bij ouderen

1 review
 74 views  3 purchases
  • Course
  • Institution
  • Book

Samenvatting van hoofdstuk 8 farmacotherapie bij ouderen uit het boek, Leerboek Geriatrie, probleemgeoriënteerd werken met ouderen.

Preview 3 out of 17  pages

  • No
  • Hoofdstuk 8
  • July 3, 2020
  • 17
  • 2019/2020
  • Summary

1  review

review-writer-avatar

By: pascalvandentempel • 3 year ago

avatar-seller
Samenvatting farmacotherapie bij ouderen
Inhoud
Welke aspecten van het ouder worden zijn belangrijk voor de farmacotherapie bij ouderen?.............3
Innameproblemen..................................................................................................................................3
farmacokinetische veranderingen..........................................................................................................3
absorptie............................................................................................................................................3
Verdeling............................................................................................................................................3
Eiwitbinding........................................................................................................................................4
eliminatie door lever..........................................................................................................................4
eliminatie door nieren........................................................................................................................4
Geneesmiddelen waarvan de dosering moet worden aangepast aan de nierfunctie.............................5
Start low, go slow...............................................................................................................................5
farmacodynamische veranderingen.......................................................................................................5
Evenwicht en valrisico........................................................................................................................6
Bloeddruk...........................................................................................................................................6
Temperatuur......................................................................................................................................6
Delier en andere anticholinerge effecten...........................................................................................6
Geneesmiddelen met sterk anticholinerge effecten.......................................................................7
Immuunsysteem.................................................................................................................................7
geneesmiddelgebonden bijwerkingen....................................................................................................7
Rationeel voorschrijven bij ouderen.......................................................................................................8
Polyfarmacie en geneesmiddelgerelateerde problemen........................................................................8
Ongeschikt geneesmiddel...................................................................................................................8
Onderbehandeling..............................................................................................................................8
Criteria om al dan niet te behandelen................................................................................................8
Deprescribing.....................................................................................................................................8
Risicogeneesmiddelen........................................................................................................................9
Nierfunctie........................................................................................................................................10
Therapietrouw..................................................................................................................................10
Medicatiebeoordeling......................................................................................................................10
STRIP.............................................................................................................................................10
Screeningsinstrumenten...................................................................................................................11
Medicatieoverdracht (Richtlijn overdracht van medicatiegegevens in de keten).............................11
Klinisch relevant voorschrijven.........................................................................................................12
Stopzetten van farmacotherapie in het kader van palliatieve zorg......................................................12

, Hart en vaten....................................................................................................................................12
1. Nitraten....................................................................................................................................12
2. Diuretica...................................................................................................................................12
3. Antihypertensiva.......................................................................................................................12
4. Digoxin......................................................................................................................................13
5. Cholesterolverlagende middelen..............................................................................................13
6. Acetylsalicylzuur.......................................................................................................................13
Zenuwstelsel.....................................................................................................................................13
7. Antipsychotica..........................................................................................................................13
8. Benzodiazepinen.......................................................................................................................13
9. Antidepressiva..........................................................................................................................13
10. Cholinesteraseremmers..........................................................................................................14
Maag-darmkanaal en endocrien stelsel............................................................................................14
11. Laxativa...................................................................................................................................14
12. Protonpompremmers.............................................................................................................14
13. Glucoseverlagende middelen en insuline...............................................................................14
Skelet................................................................................................................................................14
14. Bisfosfonaten..........................................................................................................................14
Opstarten van comforttherapie in het kader van palliatieve zorg........................................................14
Zenuwstelsel.........................................................................................................................................14
Delier................................................................................................................................................14
Angst.................................................................................................................................................14
Pijn....................................................................................................................................................15
Insomnia...........................................................................................................................................15
Maag-darmkanaal.................................................................................................................................15
Nausea en braken.............................................................................................................................15
Obstipatie.........................................................................................................................................15
Luchtwegen..........................................................................................................................................16
Dyspnoe............................................................................................................................................16
Excessief respiratoir secreet (doodsreutel)......................................................................................16
Medicatie in de laatste levensfase.......................................................................................................16

, Welke aspecten van het ouder worden zijn
belangrijk voor de farmacotherapie bij ouderen?
- Farmacokinetiek en farmacodynamiek verandert door verouderingsproces
- Individueel grote verschillen.



Innameproblemen
- Verminderde motiliteit slokdarm en maag  grote dragees kunnen blijven steken 
ontstaan perforatie, ulceratie of piloesofagitis.
o Vooral bij;
 Tetracyclines, kinidinesulfaat, kaliumdragees, acetylsalicylzuur en orale
bisfosfonaten.
o Daardoor hebben vloeibare toedieningsvormen voorkeur.
- Strips als verpakking zijn soms lastig  moeilijk eruit te krijgen, of mee innemen aluminium
- Bij cognitieve problemen en medicatie te lang in de mond houden  ulcus in de mondholte.




farmacokinetische veranderingen
absorptie
o vaker achloorhydrie; in de maag geen zoutzuur waardoor verhoogde pH in de maag.
 ook protonpompremmers verhogen ph in de maag
 geneesmiddelen die pH-afhankelijke absorptie hebben kunnen daardoor
een ander absorptieprofiel krijgen
 sommige medicatie wordt beter opgenomen in een zure maag
 sommige antischimmelmiddelen, zoals itraconazol en ketoconazol.
 Deze medicatie innemen met zure vloeistof (bijv Cola) lukt dat niet
 inname met vetrijke maaltijd aanbevolen.
 Bij inname in drankvorm zijn bovenstaande voorzorgen niet nodig.
Verdeling
o Percentage vetweefsel in verhouding tot totale hoeveelheid lichaamswater neemt
toe en Lean body mass neemt af  verdeling van vet- en wateroplosbare
geneesmiddelen wordt anders.
 Lipofiele middelen  groter (fictief) verdelingsvolume dan bij jongere
volwassenen ivm toename vetcompartiment.
 Diazepam bijv cumuleert in vetweefsel en de halveringstijd neemt
sterk toe  werking houdt langer aan.
 Hydrofiele middelen  oplaaddosis zal lager worden gekozen door afname
watercompartiment
 Extra alertheid bij geneesmiddelen die geringe therapeutische
breedte hebben
o Lithium, digoxine en gentamicine.
o Start low, go slow!!
 monitoren bloedspiegels geeft inzicht in cumulatie en evt. noodzaak tot
dosisaanpassing.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller itterse_jolien. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $4.82. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

52510 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$4.82  3x  sold
  • (1)
Add to cart
Added